The first  consortium meeting of the REGENERAR project happened on March 22.

Regenerar, led by the University of Coimbra (UC), is a  pioneering project  aiming to revolutionize the treatment landscape for neurological diseases by harnessing cutting-edge epigenetic editing techniques. With a substantial funding injection of approximately three million euros from the European Commission’s Pathfinder Open program, REGENERAR sets out to develop novel technologies facilitating neuronal regeneration. Under the guidance of lead researcher Lino Ferreira, the project seeks to exploit epigenetic tools to reprogram brain cells into functional neurons, offering new hope for conditions such as stroke and neurodegenerative diseases.

The project integrates  highly-skilled  partners including the Helmholtz Center in Munich, Fraunhofer Institute for Toxicology and Experimental Medicine, Single Technologies AB, Hovione Farmaciência SA, and Sociedade Portuguesa de Inovação.  The  consortium meeting was one of the first steps  to foster interdisciplinary collaboration and pave the way for translational research.

Together, this dynamic consortium will chart a course for the future of neurological therapeutics, with tomorrow’s meeting marking the commencement of this transformative journey.